You have 9 free searches left this month | for more free features.

City

Birmingham (1)

Huixquilucan (1)

Madison (1)

Nashville (1)

Portland (1)

Condition

Multiple Myeloma (2)

Overall Status

Active, not recruiting (1)

Withdrawn (1)

Sign in for free

Phase

phase 2 (1)

phase 3 (1)

Sponsor

Grupo Cooperativo de Hemopatias Malignas (1)

University of Alabama at Birmingham (1)

Collaborator

Amgen (1)

Janssen Scientific Affairs, LLC (1)

Intervention

daratumumab only product in parenteral dose form (1)

krdd followed by auto-hct (1)

krdd only (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

KRdD

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Multiple Myeloma Trial in United States (KRdD followed by auto-HCT, KRdD only)

Active, not recruiting

Multiple Myeloma

KRdD followed by auto-HCT
KRdD only

Birmingham, Alabama
+3 more

Mar 26, 2022

Multiple Myeloma Trial in Huixquilucan (Daratumumab Only Product in Parenteral Dose Form)

Withdrawn

Multiple Myeloma

Daratumumab Only Product in Parenteral Dose Form

Huixquilucan, Estado De México, Mexico

Grupo Cooperativo de Hemopatías Malignas

Jul 5, 2021